Diagnostic Approach for Polycystic Ovary Syndrome (PCOS)
The diagnosis of PCOS requires at least two of the following three criteria: chronic anovulation/oligo-amenorrhea, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. 1, 2
Initial Evaluation
History and Physical Assessment
- Menstrual patterns: Cycle length >35 days suggests chronic anovulation; even slightly irregular cycles (32-36 days) warrant assessment 1
- Hyperandrogenism symptoms:
- Metabolic symptoms: Weight gain, skin tags, acanthosis nigricans (insulin resistance) 1
Laboratory Testing
First-line tests:
Additional testing to exclude differential diagnoses:
- 17-hydroxyprogesterone (to rule out non-classic congenital adrenal hyperplasia) 1, 4
- Overnight dexamethasone suppression test or 24-hour urinary free cortisol (if Cushing's syndrome suspected) 4
- Mid-luteal phase progesterone (<6 nmol/L indicates anovulation) 1
- Fasting glucose/insulin ratio (>4 suggests normal insulin sensitivity) 1
Ultrasound Evaluation
- Preferred approach: Transvaginal ultrasound (if sexually active and acceptable to patient) 5
- Diagnostic criteria for polycystic ovarian morphology:
Important: Ultrasound should NOT be used for PCOS diagnosis within 8 years of menarche due to high incidence of multi-follicular ovaries in this life stage 5, 1
Diagnostic Criteria and Phenotypes
According to the Rotterdam criteria, PCOS diagnosis requires at least two of three features 2, 6:
- Oligo/anovulation
- Clinical and/or biochemical hyperandrogenism
- Polycystic ovaries on ultrasound
This results in four phenotypes:
- Phenotype A: Anovulation + hyperandrogenism + PCO (complete phenotype)
- Phenotype B: Anovulation + hyperandrogenism (without PCO)
- Phenotype C: Hyperandrogenism + PCO (ovulatory PCOS)
- Phenotype D: Anovulation + PCO (without hyperandrogenism) 5
Important Considerations
Anti-Müllerian Hormone (AMH)
- Current recommendation: Serum AMH levels should NOT be used as an alternative for detecting PCOM or as a single test for PCOS diagnosis 5, 1
- Despite promising research showing high sensitivity and specificity in various studies (AUC values ranging from 0.67-0.956), standardization of assays and established cut-off levels are still needed 5
Differential Diagnosis
Always exclude other causes of hyperandrogenism and menstrual irregularity:
- Thyroid disorders
- Hyperprolactinemia
- Non-classic congenital adrenal hyperplasia
- Cushing's syndrome
- Androgen-secreting tumors (consider if rapid onset, severe symptoms, virilization)
- Exogenous androgens
- Acromegaly
- Primary ovarian failure 1, 4
Special Populations
Adolescents:
- Diagnosis is challenging as many PCOS features overlap with normal puberty
- Persistent oligomenorrhea 2-3 years post-menarche suggests underlying dysfunction
- Hyperandrogenism is central to presentation in adolescents
- Ultrasound not recommended in girls <17 years due to common multicystic ovaries 1, 3
Postmenopausal women:
- No consistent phenotype
- Diagnosis more challenging 2
Pitfalls to Avoid
Relying solely on ultrasound: In patients with irregular menstrual cycles and hyperandrogenism, ultrasound is not necessary for diagnosis 5
Using AMH as a diagnostic test: Despite promising research, AMH is not yet validated as a diagnostic tool 5, 1
Misdiagnosing isolated polycystic ovaries as PCOS: PCO morphology alone is found in 17-22% of women without the full syndrome 1
Missing serious underlying conditions: Always consider androgen-secreting tumors in cases of rapid-onset, severe hyperandrogenism with virilization 3, 4
Premature diagnosis in adolescents: Menstrual irregularities and varied cycle length are common in the first 2-3 years post-menarche 3